An investigation on the physical properties of cementitious pastes modified with low dosage of waste glass powder and silica fume.

Portland cement (PC) production is among the industrial activities that most emit harmful gases. Its replacement to green binders turns into a timely issue to face the global restrictions due to climate changes. In this study, some properties of cementitious pastes prepared with waste packing glass powder (GP) and silica fume (SF) were characterized in line with a prefixed alkaline equivalent limit.

Psilocybin induces dose-dependent changes in functional network organization in rat cortex.

Psilocybin produces an altered state of consciousness in humans and is associated with complex spatiotemporal changes in brain networks. Given the emphasis on rodent models for mechanistic studies, there is a need for characterization of the effect of psilocybin on brain-wide network dynamics. Previous rodent studies of psychedelics, using electroencephalogram, have primarily been done with sparse electrode arrays that offered limited spatial resolution precluding network level analysis, and have been restricted to lower gamma frequencies.

Structural basis for partial agonism in 5-HT receptors.

Hyperactivity of serotonin 3 receptors (5-HTR) underlies pathologies associated with irritable bowel syndrome and chemotherapy-induced nausea and vomiting. Setrons, a class of high-affinity competitive antagonists, are used in the treatment of these conditions. Although generally effective for chemotherapy-induced nausea and vomiting, the use of setrons for treating irritable bowel syndrome has been impaired by adverse side effects.

Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain.

There is a renewed interest in psychedelic drugs as potential therapeutic agents for the treatment of psychiatric disorders. In particular, psilocybin has shown promise for the treatment of refractory depression and major depressive disorder, and has also been explored as a treatment for tobacco and alcohol abuse. However, despite suggestive evidence, there has been no systematic study to investigate the effectiveness of psilocybin in attenuating indices of chronic pain.